Following the massive success of PRIME, the influencer has attached himself to a new beverage project guaranteeing consumers an immediate, clinically recognizable cardiac event.
The multi-hyphenate creator has officially set a Q3 rollout for FLUTTR, a lifestyle beverage engineered from the ground up to push the human resting heart rate above 130 beats per minute. Reps for Paul confirmed the brand extension leverages a proprietary blend of unregulated taurine derivatives and 800 milligrams of synthetic caffeine to ensure rapid physiological panic across the highly coveted 12-to-15 demographic.
WME, which packaged the venture, is currently fielding eight-figure distribution offers from major retail partners eager to capitalize on the medical-grade stimulant.
The modern consumer is incredibly fractured, and if they don't feel their sternum vibrating against their ribcage within three sips, they assume the brand is inauthentic.
Tracking data suggests the impending launch will easily clear initial projections, with Target and Walmart already committing to front-of-store endcaps. Sources familiar with the rollout note the beverage successfully skirted FDA classification by legally designating itself as an industrial solvent with recreational applications, bypassing regulatory hurdles that traditionally stall consumer packaged goods expansions.
The impending press tour will reportedly feature Paul downing the formula while hooked up to a live EKG monitor. His camp is also aggressively shopping a behind-the-scenes docuseries to Netflix chronicling the drink's grueling R&D phase, which allegedly involved pushing a focus group of Ohio middle schoolers into sustained atrial fibrillation.